Viewing StudyNCT00049998



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00049998
Status: COMPLETED
Last Update Posted: 2013-03-04
First Post: 2002-11-18

Brief Title: Oral Topotecan Versus Intravenous Docetaxel In Pretreated Advanced Non-Small Cell Lung Cancer
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Non-Small-Cell Lung Cancer
Keywords:
Name View
docetaxel View
Nonsmall Cell Lung cancer View
advanced View
Second-line View
topotecan View
Hycamtin View
oral View